| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q2 2026 | 13 | 430,810 | PCRX, NOMD, MBIN, INMD | 13F-HR | 8/12/2026 | 000117266126003340 |
| Q1 2026 | 11 | 372,396 | PCRX, DVA, MBIN, INMD | 13F-HR | 5/15/2026 | 000117266126002097 |
| Q4 2025 | 12 | 355,633 | PCRX, INMD, MBIN, NOMD | 13F-HR | 2/17/2026 | 000117266126000872 |
| Q3 2025 | 12 | 297,792 | PCRX, NSSC, DVA, INMD | 13F-HR | 11/14/2025 | 000117266125004796 |
| Q2 2025 | 10 | 263,966 | BBD, PCRX, DVA, NSSC | 13F-HR | 8/11/2025 | 000117266125003034 |
| Q1 2025 | 10 | 254,377 | PCRX, DVA, INMD, BBD | 13F-HR | 5/15/2025 | 000117266125002053 |
| Q4 2024 | 8 | 200,971 | INMD, PCRX, SIRI, BBD | 13F-HR | 2/14/2025 | 000117266125000952 |
| Q3 2024 | 8 | 197,972 | INMD, BBD, NSSC, SIRIUSXM HOLDINGS INC | 13F-HR | 11/14/2024 | 000117266124004970 |
| Q2 2024 | 9 | 215,630 | DVA, INMD, PCRX, BBD | RESTATEMENT | 9/10/2024 | 000117266124004076 |
| Q1 2024 | 9 | 150,339 | DVA, LSXMK, PCRX, INMD | RESTATEMENT | 9/10/2024 | 000117266124004075 |
| Q4 2023 | 8 | 101,454 | DVA, LSXMK, BBD, NSSC | 13F-HR | 2/14/2024 | 000117266124000989 |
Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each security where the latest filing since 12/18/2024 is a 13D, newest first.
| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||||
|
Pacira BioSciences, Inc.
13D/A
PCRX · 695127100
|
0% |
10/13/2026
Event 10/8/2026
|
||||
| Doma Perpetual Capital Management LLC | 0% | |||||
| DOMA1 LLC | 0% | |||||
| DOMA Perpetual LO Equity Master Fund LP | 0% | |||||
| DOMA Perpetual Partners GP LLC | 0% | |||||
| Pedro Escudero | 0% | |||||
| The John Templeton Foundation | 0% | |||||
| DOMA2 LLC | 0% | |||||
2 other securities where the latest filing is a 13G, the newest filed 8/13/2026. View all